Advertisement
Research Article| Volume 340, ISSUE 1-2, P94-98, May 15, 2014

Congenital fiber type disproportion myopathy caused by LMNA mutations

  • Sachiko Kajino
    Affiliations
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan

    Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan
    Search for articles by this author
  • Kayo Ishihara
    Affiliations
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
    Search for articles by this author
  • Kanako Goto
    Affiliations
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
    Search for articles by this author
  • Keiko Ishigaki
    Affiliations
    Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan
    Search for articles by this author
  • Satoru Noguchi
    Affiliations
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan

    Department of Clinical Development, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan
    Search for articles by this author
  • Ikuya Nonaka
    Affiliations
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan
    Search for articles by this author
  • Makiko Osawa
    Affiliations
    Department of Pediatrics, Tokyo Women's Medical University, School of Medicine, Tokyo, Japan
    Search for articles by this author
  • Ichizo Nishino
    Affiliations
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan

    Department of Clinical Development, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan
    Search for articles by this author
  • Yukiko K. Hayashi
    Correspondence
    Corresponding author at: Department of Neurophysiology Tokyo Medical University, 6-1-1 Shinjuku, Shinjuku-ku, Tokyo 160-8402, Japan. Tel.:+81 3 3351 6141; fax: +81 3 3351 6544.
    Affiliations
    Department of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan

    Department of Clinical Development, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo, Japan

    Department of Neurophysiology, Tokyo Medical University, Tokyo, Japan
    Search for articles by this author
Published:March 18, 2014DOI:https://doi.org/10.1016/j.jns.2014.02.036

      Highlights

      • LMNA mutation was found in congenital fiber type disproportion (CFTD) patients.
      • Fiber type disproportion is often seen in LMNA-related muscular dystrophy.
      • Fiber type disproportion in LMNA-myopathy is due to hypertrophy of fast fibers.
      • LMNA-myopathy should be considered whenever a diagnosis of CFTD is made.

      Abstract

      A boy, who had shown muscle weakness and hypotonia from early childhood and fiber type disproportion (FTD) with no dystrophic changes on muscle biopsy, was initially diagnosed as having congenital fiber type disproportion (CFTD). Subsequently, he developed cardiac conduction blocks. We reconsidered the diagnosis as possible LMNA-myopathy and found a heterozygous mutation in the LMNA gene. This encouraged us to search for LMNA mutations on 80 patients who met the diagnostic criteria of CFTD with unknown cause. Two patients including the above index case had heterozygous in-frame deletion mutations of c.367_369delAAG and c.99_101delGGA in LMNA, respectively. Four of 23 muscular dystrophy patients with LMNA mutation also showed fiber type disproportion (FTD). Importantly, all FTD associated with LMNA-myopathy were caused by hypertrophy of type 2 fibers as compared with age-matched controls, whereas CFTD with mutations in ACTA1 or TPM3 showed selective type 1 fiber atrophy but no type 2 fiber hypertrophy. Although FTD is not a constant pathological feature of LMNA-myopathy, we should consider the possibility of LMNA-myopathy whenever a diagnosis of CFTD is made and take steps to prevent cardiac insufficiency.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Emery A.E.
        Emery-Dreifuss muscular dystrophy - a 40 year retrospective.
        Neuromuscul Disord. 2000; 10: 228-232
        • Muchir A.
        • Bonne G.
        • van der Kooi A.J.
        • et al.
        Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B).
        Hum Mol Genet. 2000; 9: 1453-1459
        • Quijano-Roy S.
        • Mbieleu B.
        • Bönnemann C.G.
        • et al.
        De novo LMNA mutations cause a new form of congenital muscular dystrophy.
        Ann Neurol. 2008; 64: 177-186
        • Park Y.E.
        • Hayashi Y.K.
        • Goto K.
        • et al.
        Nuclear changes in skeletal muscle extend to satellite cells in autosomal dominant Emery-Dreifuss muscular dystrophy/limb-girdle muscular dystrophy 1B.
        Neuromuscul Disord. 2009; 19: 29-36
        • Komaki H.
        • Hayashi Y.K.
        • Tuburaya R.
        • et al.
        Inflammatory changes in infantile-onset LMNA-associated myopathy.
        Neuromuscul Disord. 2011; 21: 563-568
        • Banwell B.L.
        • Becker L.E.
        • Jay V.
        • et al.
        Cardiac manifestations of congenital fiber-type disproportion myopathy.
        J Child Neurol. 1999; 14: 83-87
        • Clarke N.F.
        • North K.N.
        Congenital fiber type disproportion - 30 years on.
        J Neuropathol Exp Neurol. 2003; 62: 977-989
        • Laing N.G.
        • Clarke N.F.
        • Dye D.E.
        • et al.
        Actin mutations are one cause of congenital fiber type disproportion.
        Ann Neurol. 2004; 56: 689-694
        • Clarke N.F.
        • Kolski H.
        • Dye D.E.
        • et al.
        Mutations in TPM3 are a common cause of congenital fiber type disproportion.
        Ann Neurol. 2008; 63: 329-337
        • Clarke N.F.
        • Waddell L.B.
        • Cooper S.T.
        • et al.
        Recessive mutations in RYR1 are a common cause of congenital fiber type disproportion.
        Hum Mutat. 2010; 31: E1544-E1550
        • Clarke N.F.
        • Waddell L.B.
        • Sie L.T.
        • et al.
        Mutation in TPM2 and congenital fiber type disproportion.
        Neuromuscul Disord. 2012; 22: 955-958
        • Ortolano S.
        • Tarrio R.
        • Blanco-Arias P.
        • et al.
        A novel MYH7 mutation links congenital fiber type disproportion and myosin storage myopathy.
        Neuromuscul Disord. 2011; 21: 254-262
        • Clarke N.F.
        • Kidson W.
        • Quijano-Roy S.
        • et al.
        SEPN1: associated with congenital fiber-type disproportion and insulin resistance.
        Ann Neurol. 2006; 59: 546-552
        • Keller H.
        • Finsterer J.
        • Steger C.
        • et al.
        Novel c.367_369del LMNA mutation manifesting as severe arrythmias, dilated cardiomyopathy, and myopathy.
        Heart Lung. 2012; 41: 382-386
        • Bonne G.
        • Mercuri E.
        • Muchir A.
        • et al.
        Clinical and molecular genetic spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of lamin A/C gene.
        Ann Neurol. 2000; 48: 170-180
        • Brown C.A.
        • Lanning R.W.
        • McKinney K.Q.
        • et al.
        Novel and recurrent mutation in lamin A/C in patients with Emery-Dreifuss muscular dystrophy.
        Am J Med Genet. 2001; 102: 359-367
        • Tominaga K.
        • Hayashi Y.K.
        • Goto K.
        • et al.
        Congenital myotonic dystrophy can show congenital fiber type disproportion pathology.
        Acta Neuropathol. 2010; 119: 481-486
        • Danon M.J.
        • Giometti C.S.
        • Manaligod J.R.
        • Swisher C.
        Sequential muscle biopsy changes in a case of congenital myopathy.
        Muscle Nerve. 1997; 20: 561-569
        • Shishikura K.
        • Osawa M.
        • Suzuki H.
        • et al.
        Clinical variability of congenital myopathy with type 1 fiber atrophy: a long-term observation of three cases.
        Acta Paediatr Jpn. 1994; 36: 186-193
        • Okamoto N.
        • Toribe Y.
        • Nakajima T.
        • et al.
        A girl with 1p36 deletion syndrome and congenital fiber type disproportion myopathy.
        J Hum Genet. 2002; 47: 556-559